Abstract Coronavirus disease is a viral infection affecting different organs with various morbidities and mortality. Vaccines are used to control the disease. COVID‐19 vaccines have brought many benefits but their adverse effects should not be ignored. Here, we report a case of Guillain–Barré Syndrome Following Sinopharm COVID‐19 Vaccine
Guillain-Barré syndrome (GBS) is an acute inflammatory polyradiculoneuropathy. In two-thirds of pati...
Guillain-Barré Syndrome (GBS) is a complex autoimmune disorder where a person’s own immune system da...
Several reports and studies are being conducted to this day based on the safety profile of COVID-19 ...
Various vaccines against COVID-19 have been developed since SARS-CoV-2 emerged at the end of 2019. T...
We conducted a multi-institutional study in Taiwan and a systematic review of the literature for rep...
Key Clinical Message Guillain‐Barré syndrome (GBS) is a rare but possible complication that may occu...
Abstract Patients with neurological symptoms should be enquired about recent vaccination history. It...
Various vaccines against COVID-19 have been developed since SARS-CoV-2 emerged at the end of 2019. T...
Abstract Post-vaccination adverse reactions have been reported with varying symptoms and severity ow...
Since the first-reported case of Severe Acute Respiratory Distress Syndrome-Coronavirus 2 in Decembe...
Neurological involvement after coronavirus disease (COVID-19) pneumonias is common and occurs in alm...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/171121/1/lt26279_am.pdfhttp://deepblue....
Since the introduction of mRNA technology-based and vector-based COVID-19 vaccines, adverse reaction...
Severe acute respiratory syndrome coronavirus 2 (SARS-COVID-19) is a novel coronavirus that started ...
Guillain-Barré syndrome (GBS) is an acute inflammatory polyradiculoneuropathy. In two-thirds of pati...
Guillain-Barré syndrome (GBS) is an acute inflammatory polyradiculoneuropathy. In two-thirds of pati...
Guillain-Barré Syndrome (GBS) is a complex autoimmune disorder where a person’s own immune system da...
Several reports and studies are being conducted to this day based on the safety profile of COVID-19 ...
Various vaccines against COVID-19 have been developed since SARS-CoV-2 emerged at the end of 2019. T...
We conducted a multi-institutional study in Taiwan and a systematic review of the literature for rep...
Key Clinical Message Guillain‐Barré syndrome (GBS) is a rare but possible complication that may occu...
Abstract Patients with neurological symptoms should be enquired about recent vaccination history. It...
Various vaccines against COVID-19 have been developed since SARS-CoV-2 emerged at the end of 2019. T...
Abstract Post-vaccination adverse reactions have been reported with varying symptoms and severity ow...
Since the first-reported case of Severe Acute Respiratory Distress Syndrome-Coronavirus 2 in Decembe...
Neurological involvement after coronavirus disease (COVID-19) pneumonias is common and occurs in alm...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/171121/1/lt26279_am.pdfhttp://deepblue....
Since the introduction of mRNA technology-based and vector-based COVID-19 vaccines, adverse reaction...
Severe acute respiratory syndrome coronavirus 2 (SARS-COVID-19) is a novel coronavirus that started ...
Guillain-Barré syndrome (GBS) is an acute inflammatory polyradiculoneuropathy. In two-thirds of pati...
Guillain-Barré syndrome (GBS) is an acute inflammatory polyradiculoneuropathy. In two-thirds of pati...
Guillain-Barré Syndrome (GBS) is a complex autoimmune disorder where a person’s own immune system da...
Several reports and studies are being conducted to this day based on the safety profile of COVID-19 ...
DOI
Add to ORKG